NEW YORK (GenomeWeb) – Indian genomics firm Mapmygenome today announced a pre-Series A financing round to scale up its operations. 

A company spokesperson told GenomeWeb that Mapmygenome raised INR70 million ($1.1 million) in the financing round, which was the company's first since it was founded in 2013. Mapmygenome CEO Anu Acharya said that the firm intends on expanding its leadership team, sales and marketing operations, and genetic counseling network, as well as invest in some assets to scale up its research. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.